Literature DB >> 8103748

Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition.

P M Kaye1, C Coburn, M McCrossan, S M Beverley.   

Abstract

Processing of antigen for recognition by class II-restricted CD4+ T cells occurs within acidic compartments of the antigen-presenting cell. The exact nature of this compartment has yet to be precisely defined, however, but may vary depending upon the cell type studied and the antigen used. The acidic compartments of macrophages are also responsible for the degradation of ingested micro-organisms and play host to others which are adapted to an intracellular existence. To determine whether the phagolysosome (PL) formed in activated macrophages after ingestion of Leishmania parasites is also a site for entry of antigen into the class II presentation pathway, we have used the approach of genetic transformation. Hence, Leishmania were transfected with the genes for the protein antigens ovalbumin (OVA) and beta-galactosidase (beta-gal) and after infection were able to deliver these antigens specifically into the PL. Delivery of antigen to this site resulted in the ability of infected macrophages to present these antigens to antigen-specific CD4+ T cells. After taking into account the absolute levels of antigen uptake by macrophages, a 4-h processing period for OVA delivered by this or a soluble route led to equivalent levels of T cell activation. Unlike macrophages pulsed with soluble OVA, those with PL-targeted OVA still retained the ability to stimulate T cells after a 24-h processing period. This enhanced lifespan of antigen in macrophages corresponded to the kinetics of degradation of the parasite, suggesting slow release of antigen into the processing pathway. beta-gal presentation from the PL was tenfold less efficient under the same conditions. In addition to providing the first information on antigen processing in a protozoan PL, these studies highlight the usefulness of genetically transformed parasites for these types of studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103748     DOI: 10.1002/eji.1830230939

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors:  H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.

Authors:  S Flohé; T Lang; H Moll
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  VAMP3 and VAMP8 Regulate the Development and Functionality of Parasitophorous Vacuoles Housing Leishmania amazonensis.

Authors:  Olivier Séguin; Linh Thuy Mai; Hamlet Acevedo Ospina; Marie-Michèle Guay-Vincent; Sidney W Whiteheart; Simona Stäger; Albert Descoteaux
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

4.  Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation.

Authors:  D A Smith; Q D Bickle; P M Kaye
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

5.  Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Authors:  Rosalind Polley; Simona Stager; Sara Prickett; Asher Maroof; Soombul Zubairi; Deborah F Smith; Paul M Kaye
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.

Authors:  L Carrera; R T Gazzinelli; R Badolato; S Hieny; W Muller; R Kuhn; D L Sacks
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

Review 7.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

8.  In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization.

Authors:  Sara Prickett; Peter M Gray; Sara L Colpitts; Phillip Scott; Paul M Kaye; Deborah F Smith
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.